Takahiro Koinuma

Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson’s disease

Shinji Saiki, Taku Hatano, Motoki Fujimaki et al. · Scientific Reports · 2017 · 143 citations · Full text

Life Sciences, Biochemistry, Metabolic Stability +14

Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease

Motoki Fujimaki, Shinji Saiki, Yuanzhe Li et al. · Neurology · 2018 · 103 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Parkinson’s disease-associated <i>iPLA2-VIA/</i> PLA2G6 regulates neuronal functions and α-synuclein stability through membrane remodeling

Akio Mori, Taku Hatano, Tsuyoshi Inoshita et al. · Proceedings of the National Academy of Sciences · 2019 · 96 citations · Full text

Life Sciences, Neurology, Neuroscience +15

Metabolomics‐based identification of metabolic alterations in PARK2

Ayami Okuzumi, Taku Hatano, Shin‐Ichi Ueno et al. · Annals of Clinical and Translational Neurology · 2019 · 61 citations · Full text

Life Sciences, Biochemistry, Neuroscience +17

Nonmercaptalbumin as an oxidative stress marker in Parkinson’s and PARK2 disease

Shin‐Ichi Ueno, Taku Hatano, Ayami Okuzumi et al. · Annals of Clinical and Translational Neurology · 2020 · 27 citations · Full text

Life Sciences, Neurology, Neuroscience +17